Even if gene therapy does work, how will a stretched NHS foot the bill?

The following is an excerpt.

Gene therapy is one of those medical “breakthroughs” that has unfortunately failed to live up to expectations. Several clinical trials, usually involving inherited diseases caused by defects in single genes, have ended in failure and, in at least one case, the death of patients.

But if gene therapy proves to work, the big question is whether the NHS will be able to afford yet another new treatment, costing several thousand pounds a shot. 

View the original article here: Steve Connor: Even if gene therapy does work, how will a stretched NHS foot the bill?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.